# Synergia Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synergia-medical

- Industry: Medical Devices & Equipment
- Headquarters: Belgium
- Website: www.synergiam.com
- Total disclosed funding: $9.9M
- Latest round: Series A (Feb 26, 2018)
- Investors on record: 4

## About

Based in Belgium, and founded in 2013 by Attila Borbath, and Pascal Doguet, Synergia Medical SA operates as a medical device company that focuses on medical devices and specializes in creating optoelectronic neurostimulator platforms and devices. In February 2018, Synergia Medical SA raised EUR 8.1 million in series A financing led by Newton Biocapital, with participation from Financière Spin-Off Luxembourgeoise, SFPI-FPIM, and SRIW.

Synergia Medical SA is a medical device manufacturer that focuses on optoelectronics-based technology. The company's product is intended for developing MRI-safe implantable neurostimulation devices for the treatment of drug-resistant epilepsy, as well as other therapeutic applications. Furthermore, these devices use photovoltaic cells to convert optical energy into electrical impulses instead of traditional wires. This enables medical institutions to implant neurostimulators in their patients.

## Funding rounds

- Series A, Feb 26, 2018, $9.9M — SFPI-FPIM, Financière Spin-Off Luxembourgeoise, SRIW, Newton Biocapital Partners

## Investors

- SFPI-FPIM — Series A
- Financière Spin-Off Luxembourgeoise — Series A
- SRIW — Series A
- Newton Biocapital Partners (https://capitalatlas.ai/funds/newton-biocapital-partners) — Series A